Quarry LP’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76K Sell
6
-326
-98% -$92.5K ﹤0.01% 1717
2026
Q1
$92.5K Buy
+332
New +$95.6K 0.02% 509
2025
Q4
Sell
-287
Closed -$80.5K 2162
2025
Q3
$80.5K Buy
287
+163
+131% +$44.4K 0.02% 594
2025
Q2
$29.9K Buy
124
+4
+3% +$946 0.01% 1048
2025
Q1
$29.2K Buy
+120
New +$36.1K 0.01% 1005
2024
Q4
Sell
-297
Closed -$99.4K 1639
2024
Q3
$99.4K Buy
297
+82
+38% +$26K 0.03% 431
2024
Q2
$58.7K Buy
+215
New +$62.5K 0.02% 571
2024
Q1
Sell
-84
Closed -$27.1K 1652
2023
Q4
$27.1K Buy
+84
New +$26.3K ﹤0.01% 602

Other funds holding BIO

Quarry LP's BIO Position: Q2 2026 in Review

Quarry LP reduced its Bio-Rad Laboratories Class A (BIO) stake by 98% in Q2 2026, selling an estimated $92.5K and leaving 6 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1717.

Quarry LP first reported a position in BIO in Q4 2023 and has held it in 8 quarters since. The position peaked at $99.4K in Q3 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Quarry LP held 6 shares of Bio-Rad Laboratories Class A worth $1.76K as of Q2 2026.
  • Quarry LP sold 326 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $92.5K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1717 holding.
  • Quarry LP first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 8 quarters since.
  • Quarry LP's Bio-Rad Laboratories Class A position peaked at $99.4K in Q3 2024.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.